Intrinsiqq
Aura Biosciences Inc. logo

Aura Biosciences Inc. Financials

AURA

Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 5 of 6 available years
Income Statement
DEC 2025
DEC 2024
DEC 2023
~1.3:1 split
DEC 2022
~5.8:1 split
DEC 2021
14:1 split
General & Administrative$22$23$20$18$10
Research & Development$90$73$65$42$25
Operating Income-$113-$96-$85-$60-$35
Other Non-Operating Income (Expense)$7$9$9$2-$0
EBT (Earnings Before Tax)-$106-$87-$76-$59–
Income Tax Expense$0$0$0$0$0
Net Income
Net Income-$106-$87-$76-$59-$35
EPS (Basic)-$1.76-$1.75-$1.93-$1.96-$8.95
EPS (Diluted)-$1.76-$1.75-$1.93-$1.96-$8.95
Weighted Avg Shares (Basic)60.3M49.7M39.6M29.9M5.2M
Weighted Avg Shares (Diluted)60.3M49.7M39.6M29.9M5.2M
Shares Outstanding60.3M49.7M39.6M29.9M5.2M

Aura Biosciences (AURA) financials: revenue, profit and margins

Aura Biosciences (AURA) generated about n/a in revenue and -$137 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Aura Biosciences profitable?+

Aura Biosciences reported about -$137 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 4 Nov 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 9 Nov 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with AURA

CompareIntrinsic value
CELZCreative Medical Technology Holdings Inc.
$0.40-8.14%10
VCELVericel Corporation
$57.52-1.27%65
IOVAIovance Biotherapeutics, Inc.
$6.90-5.61%10
CGONCG Oncology, Inc.
$79.47-2.97%40
TECHBio-Techne Corporation
$72.67-0.04%41
MRNAModerna, Inc.
$195.00-2.17%13
HALOHalozyme Therapeutics Inc.
$91.35-1.82%70
SCLXScilex Holding Company
$0.57-12.95%0

Held by ETFs

AURA is in 13 US ETFs. The largest of them, with AURA's weight in each:

Spot a number that looks wrong? Check it in AURA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing AURA

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.